Literature DB >> 1276536

Calcitonin: antagonism at intestinal muscarinic receptors.

C F Dreyfus, M D Gershon, A Haymovits, E Nunez.   

Abstract

The action of calcitonin was studied on the motility of isolated innervated segments of rabbit and guinea-pig intestines as well as longitudinal muscle with adherent myenteric plexus dissected from the guinea-pig ileum. Calcitonin (0.25 muM) antagonized contractile responses to acetylcholine and the cholinergic response to electrical field stimulation. This hormonal effect was relatively specific since it was not observed at nicotinic receptors or adrenoceptors, nor did calcitonin act as a local anaesthetic or directly on the contractile machinery of smooth muscle. Perivascular adrenergic and intrinsic non-adrenergic inhibitory responses also were unaffected by calcitonin. However, calcitonin did have antihistaminic properties directed against H1-receptors. The concentration of calcitonin required to achieve muscarinic antagonism in our experiments is not reached at the resting level of circulating hormone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276536      PMCID: PMC1667025          DOI: 10.1111/j.1476-5381.1976.tb07667.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

Review 1.  Calcitonin in metabolic disorders.

Authors:  A Haymovits; J F Rosen
Journal:  Adv Metab Disord       Date:  1972

2.  Human medullary thyroid carcinoma: control of calcitonin secretion in vivo and in tissue culture.

Authors:  K M Gautvik; A H Tashjian
Journal:  Horm Metab Res       Date:  1974-01       Impact factor: 2.936

Review 3.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

4.  Effects of tetrodotoxin on innervated smooth muscle preparations.

Authors:  M D Gershon
Journal:  Br J Pharmacol Chemother       Date:  1967-03

5.  Effect of calcium and calcitonin on gastrin and gastric secretion in cats.

Authors:  H D Becker; S J Konturek; D D Reeder; J C Thompson
Journal:  Am J Physiol       Date:  1973-08

6.  Inhibition of gastrin release and gastric secretion by calcitonin in patients with peptic ulcer.

Authors:  H D Becker; D D Reeder; M T Scurry; J C Thompson
Journal:  Am J Surg       Date:  1974-01       Impact factor: 2.565

Review 7.  Gastrin and its activities.

Authors:  M I Grossman
Journal:  Nature       Date:  1970-12-19       Impact factor: 49.962

8.  [Calcitonin-induced inhibition of exocrine pancreatic secretion in man].

Authors:  H Schmidt; R D Hesch; M Hüfner; K Paschen; W Creutzfeldt
Journal:  Dtsch Med Wochenschr       Date:  1971-11-05       Impact factor: 0.628

9.  Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma.

Authors:  L J Deftos; A D Goodman; K Engelman; J T Potts
Journal:  Metabolism       Date:  1971-04       Impact factor: 8.694

10.  The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips.

Authors:  W D Paton; M A Zar
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

View more
  4 in total

1.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

2.  The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

3.  Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

4.  Differences in agonist dissociation constant estimates for 5-HT at 5-HT2-receptors: a problem of acute desensitization?

Authors:  P Leff; G R Martin
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.